About 4,393 results

ALLMedicine™ Hyperbilirubinemia Center

Research & Reviews  1,457 results

Cloxacillin-induced acute vanishing bile duct syndrome: a case study and literature rev...
British Journal of Clinical Pharmacology; Faragalla K, Lau H et. al.

Jun 23rd, 2022 - Ductopenia is often regarded as a chronic process where ≥50% of portal tracts lack bile ducts, which is also known as vanishing bile duct syndrome (VBDS). One etiology is drug-induced liver injury. Cloxacillin, an anti-staphylococcal penicillin, t...

Small-for-Size Syndrome: Systemic Review in a Porcine Experimental Model.
Transplantation Proceedings; Fernandes MR, Nacif LS et. al.

Jun 18th, 2022 - The small-for-size syndrome (SFSS) is characterized by prolonged hyperbilirubinemia, coagulopathy, and/or encephalopathy caused by a small liver graft that cannot sustain the metabolic demands of the recipient after a partial liver transplant (PLT...

see more →

Guidelines  3 results

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Ata...
Clinical Pharmacology and Therapeutics; Gammal RS, Court MH et. al.

Sep 30th, 2015 - The antiretroviral protease inhibitor atazanavir inhibits hepatic uridine diphosphate glucuronosyltransferase (UGT) 1A1, thereby preventing the glucuronidation and elimination of bilirubin. Resultant indirect hyperbilirubinemia with jaundice can c...

Phototherapy to prevent severe neonatal hyperbilirubinemia in the newborn infant 35 or ...
Pediatrics Bhutani VK, et. al.

Sep 29th, 2011 - To standardize the use of phototherapy consistent with the American Academy of Pediatrics clinical practice guideline for the management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Relevant literature was reviewed. P...

Universal screening for hyperbilirubinemia.
Nursing for Women's Health;

Feb 9th, 2010 - Universal screening for hyperbilirubinemia.|2010||blood,blood,diagnosis,standards,

see more →

Drugs  39 results see all →

Clinicaltrials.gov  126 results

Effect of Tub Bathing on Skin and Bilirubin Levels in Infants Undergoing Tunnel and LED of Phototherapy

May 27th, 2022 - The study was conducted as a randomized controlled study to determine effect of tube bathing on skin and bilirubin levels in infants undergoing tunnel and LED of phototherapy. The population of the study consisted of term babies with the diagnosis...

Risk Factor for Cholestasis in Neonates Receiving TPN(Total Parenteral Nutrition)

May 20th, 2022 - Neonates with prematurity,gastrointestinal dysfunction and very low birth weights are often intolerant to oral feeding.In such infants,the provision of nutrients via parenteral nutrition (PN)becomes necessary for short term survival,as well as lon...

Gestational Diabetes and Pharmacotherapy (GAP)

May 13th, 2022 - Gestational diabetes mellitus (GDM) affects 5-8% of pregnant women, many of whom will require treatment beyond diet and exercise. Despite this high prevalence, there is no consensus regarding the glycemic threshold for conversion from diet to medi...

Supplemental Nursing System Compared to Bottle Supplementation

May 12th, 2022 - Supplemental feedings in the neonatal intensive care unit (NICU) are common due to the separation of mother and neonate and/or complex medical issues that make direct breastfeeding difficult. The Supplemental Nursing System (SNS) is utilized infre...

Assessment of Neonatal Hyperbilirubinemia by NeoprediX B.1 Algorithm

May 3rd, 2022 - Neonatal jaundice is common and mostly transient without need for intervention. To identify infants at risk of bilirubin toxicity, bilirubin is measured several times after birth and before discharge home. As the peak bilirubin concentrations are ...

see more →

News  132 results

Frontline Lenvatinib/TACE Improves OS in Advanced HCC

Jan 22nd, 2022 - Transarterial chemoembolization (TACE) plus lenvatinib (Lenvima) led to a significant improvement in overall survival (OS) vs lenvatinib alone as frontline therapy in patients with advanced hepatocellular carcinoma (HCC), according to findings fro...

Challenges in Early Detection of GvHD

Jan 21st, 2022 - Yi-Bin Chen, MD: A lot of research has gone into early detection of graft-vs-host disease [GVHD]. It’s difficult to detect graft-vs-host disease early because we’d all admit that the immune response takes weeks before we see the manifestation. Why...

Chemotherapy With FOLFOX Superior to TACE in Liver Cancer

Nov 11th, 2021 - Hepatic arterial infusion chemotherapy (HAIC) with FOLFOX led to superior patient outcomes and less toxicity than standard of care transarterial chemoembolization (TACE) for patients with large, unresectable hepatocellular carcinoma (HCC), a rando...

Chemotherapy with FOLFOX superior to TACE in liver cancer
Pam Harrison

Nov 10th, 2021 - Hepatic arterial infusion chemotherapy (HAIC) with FOLFOX led to superior patient outcomes and less toxicity than standard of care transarterial chemoembolization (TACE) for patients with large, unresectable hepatocellular carcinoma (HCC), a rando.

Expert Recaps Advances in AML

Oct 6th, 2021 - Rami S. Komrokji, MD Now that physicians have access to novel therapies for patients with acute myeloid leukemia (AML) following a 30-year gap in therapeutic development, physicians must now aim to understand their optimal placement in treatment,...

see more →